Jun 28, 2024 · Myasthenia gravis (MG) is a rare, acquired autoimmune disorder of the neuromuscular junction, characterized by fatigable muscle weakness in the voluntary muscles. …

Mar 25, 2025 · Nicholas J. Silvestri, MD, expects that the upcoming 2025 American Academy of Neurology Annual Meeting in San Diego will be an exciting event for the field of myasthenia …

Jul 12, 2024 · Myasthenia gravis is an example of a very treatable neurologic condition in most cases. We've had many therapies for many decades. And thankfully, we've been blessed to …

Jun 22, 2023 · Anyone with newly diagnosed myasthenia gravis — especially if they are acetylcholine receptor-positive — needs a CT scan of the chest, because about 15% to 20% …

Mar 25, 2025 · Dr Nicholas Silvestri shares AAN 2025 highlights, including anticipated presentations, quick takeaways, and insights on the impact of new myasthenia gravis research.

Nov 4, 2024 · Promising Results for Investigational Myasthenia Gravis Drug Sustained Control With Investigational Monoclonal Antibody for Myasthenia Gravis 3090D553-9492-4563-8681 …

Jul 1, 2024 · Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular junction, characterized by fluctuating muscle weakness.. Nicholas J. Silvestri, MD. A steady …

May 2, 2023 · There has been an increase in the incidence and prevalence of myasthenia gravis (MG) in the United States, an analysis of new claims data shows.. Investigators speculate the …

Feb 16, 2021 · Myasthenia gravis is a disorder of neuromuscular transmission, resulting from autoantibodies to components of the neuromuscular junction, most commonly the …

Apr 3, 2024 · Robeson: The Myasthenia Gravis Foundation of America is a great resource for both patients and providers. There's a provider section that has links to all of our current …